Tagreed Alkaltham: Why Apheresis Matters in Modern Transfusion Medicine
Tagreed Alkaltham, Transfusion Medicine Lab Supervisor at KSMC, shared a post on LinkedIn:
”Why Apheresis Matters in Modern Transfusion Medicine?
Apheresis is not important simply because it is advanced technology.
- It matters because modern transfusion medicine is no longer built around ‘collecting blood’ alone.
- It is increasingly built around collecting the right component, in the right dose, for the right clinical purpose.
That distinction changed everything.
Traditional whole blood donation remains essential and irreplaceable in transfusion medicine.
But apheresis introduced something different: targeted component collection.
Instead of collecting all blood components together and separating them later, apheresis allows specific components to be selectively collected while the remaining components are safely returned to the donor.
That level of selectivity created new clinical and operational possibilities.
Higher targeted component yield:
Apheresis can collect larger or more concentrated amounts of a desired component during a single procedure.
For example: single donor platelet collections may provide therapeutic platelet doses from one donor rather than pooling platelets from multiple donations.
In many settings, this may help reduce donor exposure for recipients who require repeated transfusion support.
More precise component strategy:
Not every patient requires the same transfusion approach.
Some patients primarily need:
- platelets
- plasma
- red cell exchange
- or selective therapeutic removal of pathologic components.
Apheresis supports a more focused transfusion strategy based on clinical indication rather than generalized replacement alone.
This is where transfusion medicine becomes increasingly aligned with precision based care.
Therapeutic applications beyond donation:
Apheresis is not limited to collection.
It also supports therapeutic interventions such as:
- therapeutic plasma exchange
- red cell exchange
- leukapheresis
- and stem cell collection.
In some clinical situations, apheresis becomes part of active disease management, not only transfusion support.
Inventory and operational impact:
- Apheresis may also support inventory management and component availability in specialized settings.
- Targeted collection strategies can help blood centers and transfusion services respond more effectively to specific clinical demands, shortages, or high utilization component needs.
Because modern blood banking is not only about supply.
It is also about precision allocation and component stewardship.
But the importance of apheresis is not defined by the machine itself.
It is defined by the clinical philosophy behind it:
- collect intentionally
- monitor carefully
- minimize unnecessary exposure
- and match therapy more precisely to patient need.
Modern transfusion medicine is moving from generalized collection… to targeted component strategy.
And apheresis is one of the technologies helping drive that transition.”
Stay updated with Hemostasis Today.
-
May 12, 2026, 16:37Reinhold Kreutz: Cardiovascular Burden in Acute Intermittent Porphyria Needs Greater Awareness
-
May 12, 2026, 16:33Pablo Corral: The Truth About Very Low LDL-Cholesterol
-
May 12, 2026, 16:24Mildred Lundgren: We Must Talk About the Invisible Causes of Stroke
-
May 12, 2026, 16:17Irene Scala: The Sex Disparities In Access to Acute Stroke Treatments In Italy
-
May 12, 2026, 16:04May Nour: UCLA Health Mobile Stroke Unit Becomes The 1st In The World to Perform mCTA In the Field
-
May 12, 2026, 15:57Leonardo Roever: Prognostic Impact of Lipoprotein(a) and CAR in Elderly Acute Ischemic Stroke Patients
-
May 12, 2026, 15:54Bruno Pougault: Prioritizing Laboratory Tests in Resource-Limited Emergency Care
-
May 12, 2026, 15:37Jennifer Holter Chakrabarty: Supporting the Next Generation of Hematology Researchers
-
May 12, 2026, 15:21Joseph Mmwa: Blood Donation Debate Sparks Concern Across Kenya